ANTIBIOTIC RESISTANCE AND TREATMENT OUTCOMES IN PEDIATRIC COMMUNITY-ACQUIRED PNEUMONIA: A SYSTEMATIC REVIEW
Keywords:
Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Electronic databases including PubMed, Scopus, EmbaseAbstract
Community-acquired pneumonia (CAP) becomes one of the main causes of morbidity and mortality among children worldwide. Increasing antimicrobial resistance among respiratory pathogens creates difficulties in empirical antibiotic therapy and negatively affects recovery outcomes. This systematic review evaluated antibiotic resistance patterns and related clinical outcomes in pediatric CAP
Electronic databases including PubMed, Scopus, Embase, and Web of Science were searched for articles published between January 2015 and March 2026. Studies evaluating antimicrobial resistance patterns and patient outcomes among pediatric CAP patients were included. Data extraction and methodological quality assessment were carried out independently by reviewers according to PRISMA guidelines.
The review indicated increasing resistance to macrolides, penicillins, and cephalosporins in common respiratory pathogens. Resistant infections were connected with prolonged hospitalization, delayed recovery, increased ICU admission, and greater healthcare spendings. Antimicrobial management and vaccination programs showed considerable benefits in reducing resistant infections and improving patient quality of life.
Antibiotic resistance is considered a major challenge in pediatric CAP management. Continued monitoring, clinically approved prescribing, and implementation of antimicrobial stewardship programs are very important for optimizing pediatric care and preventing the spread of resistance.
References
World Health Organization. Pneumonia. Geneva: WHO; 2025.
Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children. Clin Infect Dis. 2011;53(7):617-630.
Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835-845.
Principi N, Esposito S. Antimicrobial stewardship in pediatric infections. Ital J Pediatr. 2016;42:87.
Waites KB, Xiao L, Liu Y, et al. Mycoplasma pneumoniae from the respiratory tract and beyond. Clin Microbiol Rev. 2017;30(3):747-809.
Ouldali N, Yang DD, Madhi F, et al. Antibiotic resistance in childhood pneumonia. Lancet Infect Dis. 2023;23(4):e120-e130.
Lodha R, Kabra SK. Antibiotics for pediatric pneumonia. Indian J Pediatr. 2018;85(5):377-383.
Ginsburg AS, Klugman KP. Vaccination to reduce childhood pneumonia. Lancet Glob Health. 2017;5(12):e1173-e1174.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles published in IQRO — Scientific Methodological Journal are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
Authors retain copyright and grant the journal the right of first publication.
Users may read, download, copy, distribute, print, search, or link to the full texts of articles, provided that the original authors and the journal are properly cited.
Published materials may be used, distributed, and reproduced in any medium, provided that the original work is properly cited.



Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo